{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:09:53Z","timestamp":1790356193162,"version":"4.1.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T00:00:00Z","timestamp":1566172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T00:00:00Z","timestamp":1566172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA213385"],"award-info":[{"award-number":["CA213385"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008308","name":"Comprehensive Cancer Center, City of Hope","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008308","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The \u201cbaby boomers\u201d born in 1946\u20131964 in the United States (U.S.) started to reach the age of 65 in 2011, rapidly accelerating U.S. population aging. There are great public concerns about its impact on health care with anticipation of rising cancer incidences. We examined the incidences and deaths of leukemia and overall cancer in the U.S. from 1998 to 2018. The acute myeloid leukemia (AML) and chronic myeloid leukemia (CML) incidences remained constant prior to 2011 but have climbed up substantially since then, and the chronic lymphocytic leukemia (CLL) incidence has increased continuously since 1998. The significant increase of myeloid leukemia and CLL incidences was strongly correlated with the U.S. population aging. The incidence of all cancers was increased in correlation with a small increase in aging population prior to 2011, but surprisingly has changed marginally since 2011, which was not significantly correlated with the accelerated population aging. We observed the most substantial decline of deaths with CML, whereas AML deaths continued to rise in the past 20 years. In conclusion, the overall cancer incidence was not increased as fast as previously feared with aging Americans; however, the incidences of myeloid leukemia and CLL significantly outpaced that of all cancers.<\/jats:p>","DOI":"10.1038\/s41598-019-48445-1","type":"journal-article","created":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T10:04:06Z","timestamp":1566209046000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["An emerging trend of rapid increase of leukemia but not all cancers in the aging population in the United States"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5213-3428","authenticated-orcid":false,"given":"Taisen","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li-Talley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Buck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WenYong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,19]]},"reference":[{"key":"48445_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2018. CA: a cancer journal for clinicians 68, 7\u201330, https:\/\/doi.org\/10.3322\/caac.21442 (2018).","journal-title":"CA: a cancer journal for clinicians"},{"key":"48445_CR2","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1002\/cncr.32034","volume":"125","author":"FM Ghazawi","year":"2019","unstructured":"Ghazawi, F. M. et al. Analysis of acute myeloid leukemia incidence and geographic distribution in Canada from 1992 to 2010 reveals disease clusters in Sarnia and other industrial US border cities in Ontario. Cancer 125, 1886\u20131897, https:\/\/doi.org\/10.1002\/cncr.32034 (2019).","journal-title":"Cancer"},{"key":"48445_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-018-3225-9","volume":"11","author":"R Snodgrass","year":"2018","unstructured":"Snodgrass, R. et al. Incidence of acute lymphocytic leukemia in Calgary, Alberta, Canada: a retrospective cohort study. BMC research notes 11, 104, https:\/\/doi.org\/10.1186\/s13104-018-3225-9 (2018).","journal-title":"BMC research notes"},{"key":"48445_CR4","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10552-018-1004-5","volume":"29","author":"M Solans","year":"2018","unstructured":"Solans, M. et al. Challenges in assessing the real incidence of chronic lymphocytic leukemia: 16 years of epidemiological data from the province of Girona, Spain. Cancer causes & control: CCC 29, 379\u2013382, https:\/\/doi.org\/10.1007\/s10552-018-1004-5 (2018).","journal-title":"Cancer causes & control: CCC"},{"key":"48445_CR5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000486228","volume":"139","author":"X Song","year":"2018","unstructured":"Song, X. et al. Incidence, Survival, and Risk Factors for Adults with Acute Myeloid Leukemia Not Otherwise Specified and Acute Myeloid Leukemia with Recurrent Genetic Abnormalities: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database, 2001\u20132013. Acta haematologica 139, 115\u2013127, https:\/\/doi.org\/10.1159\/000486228 (2018).","journal-title":"Acta haematologica"},{"key":"48445_CR6","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.rce.2016.05.003","volume":"216","author":"J Garcia-Suarez","year":"2016","unstructured":"Garcia-Suarez, J. & Gil-Fernandez, J. J. Epidemiology of chronic myeloid leukemia in Spain and its possible therapeutic implications. Revista clinica espanola 216, 311\u2013312, https:\/\/doi.org\/10.1016\/j.rce.2016.05.003 (2016).","journal-title":"Revista clinica espanola"},{"key":"48445_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.amepre.2011.04.003","volume":"41","author":"SB Mohr","year":"2011","unstructured":"Mohr, S. B., Garland, C. F., Gorham, E. D., Grant, W. B. & Garland, F. C. Ultraviolet B and incidence rates of leukemia worldwide. American journal of preventive medicine 41, 68\u201374, https:\/\/doi.org\/10.1016\/j.amepre.2011.04.003 (2011).","journal-title":"American journal of preventive medicine"},{"key":"48445_CR8","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/ijc.27542","volume":"131","author":"JC Teepen","year":"2012","unstructured":"Teepen, J. C. & van Dijck, J. A. Impact of high electromagnetic field levels on childhood leukemia incidence. Int J Cancer 131, 769\u2013778, https:\/\/doi.org\/10.1002\/ijc.27542 (2012).","journal-title":"Int J Cancer"},{"key":"48445_CR9","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1124\/pr.55.3.4","volume":"55","author":"MW Deininger","year":"2003","unstructured":"Deininger, M. W. & Druker, B. J. Specific targeted therapy of chronic myelogenous leukemia with imatinib. Pharmacol Rev 55, 401\u2013423 (2003).","journal-title":"Pharmacol Rev"},{"key":"48445_CR10","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1056\/NEJMoa062867","volume":"355","author":"BJ Druker","year":"2006","unstructured":"Druker, B. J. et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 355, 2408\u20132417 (2006).","journal-title":"N Engl J Med"},{"key":"48445_CR11","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/35041694","volume":"408","author":"RA DePinho","year":"2000","unstructured":"DePinho, R. A. The age of cancer. Nature 408, 248\u2013254 (2000).","journal-title":"Nature"},{"key":"48445_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/MAJ.0000000000000281","volume":"348","author":"JP Thakkar","year":"2014","unstructured":"Thakkar, J. P., McCarthy, B. J. & Villano, J. L. Age-specific cancer incidence rates increase through the oldest age groups. The American journal of the medical sciences 348, 65\u201370, https:\/\/doi.org\/10.1097\/MAJ.0000000000000281 (2014).","journal-title":"The American journal of the medical sciences"},{"key":"48445_CR13","doi-asserted-by":"publisher","first-page":"5524","DOI":"10.1073\/pnas.0305300101","volume":"101","author":"JM Dhahbi","year":"2004","unstructured":"Dhahbi, J. M., Kim, H. J., Mote, P. L., Beaver, R. J. & Spindler, S. R. Temporal linkage between the phenotypic and genomic responses to caloric restriction. Proc Natl Acad Sci USA 101, 5524\u20135529 (2004).","journal-title":"Proc Natl Acad Sci USA"},{"key":"48445_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/00324728.2014.958192","volume":"69","author":"HA Hanson","year":"2015","unstructured":"Hanson, H. A., Smith, K. R., Stroup, A. M. & Harrell, C. J. An age-period-cohort analysis of cancer incidence among the oldest old, Utah 1973\u20132002. Population studies 69, 7\u201322, https:\/\/doi.org\/10.1080\/00324728.2014.958192 (2015).","journal-title":"Population studies"},{"key":"48445_CR15","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1002\/cncr.26376","volume":"118","author":"C Harding","year":"2012","unstructured":"Harding, C., Pompei, F. & Wilson, R. Peak and decline in cancer incidence, mortality, and prevalence at old ages. Cancer 118, 1371\u20131386, https:\/\/doi.org\/10.1002\/cncr.26376 (2012).","journal-title":"Cancer"},{"key":"48445_CR16","doi-asserted-by":"publisher","unstructured":"Pedersen, J. K. et al. Declining cancer incidence at the oldest ages: Hallmark of aging or lower diagnostic activity? Journal of geriatric oncology, https:\/\/doi.org\/10.1016\/j.jgo.2019.02.001 (2019).","DOI":"10.1016\/j.jgo.2019.02.001"},{"key":"48445_CR17","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/cncr.22233","volume":"107","author":"B Deschler","year":"2006","unstructured":"Deschler, B. & Lubbert, M. Acute myeloid leukemia: epidemiology and etiology. Cancer 107, 2099\u20132107, https:\/\/doi.org\/10.1002\/cncr.22233 (2006).","journal-title":"Cancer"},{"key":"48445_CR18","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/ajh.24826","volume":"92","author":"M Hallek","year":"2017","unstructured":"Hallek, M. Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment. Am J Hematol 92, 946\u2013965, https:\/\/doi.org\/10.1002\/ajh.24826 (2017).","journal-title":"Am J Hematol"},{"key":"48445_CR19","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.3109\/10428194.2012.745525","volume":"54","author":"Y Chen","year":"2013","unstructured":"Chen, Y., Wang, H., Kantarjian, H. & Cortes, J. Trends in chronic myeloid leukemia incidence and survival in the United States from 1975 to 2009. Leukemia & lymphoma 54, 1411\u20131417, https:\/\/doi.org\/10.3109\/10428194.2012.745525 (2013).","journal-title":"Leukemia & lymphoma"},{"key":"48445_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.mad.2017.05.002","volume":"164","author":"SC Nolen","year":"2017","unstructured":"Nolen, S. C. et al. Cancer-Incidence, prevalence and mortality in the oldest-old. A comprehensive review. Mech Ageing Dev 164, 113\u2013126, https:\/\/doi.org\/10.1016\/j.mad.2017.05.002 (2017).","journal-title":"Mech Ageing Dev"},{"issue":"Suppl 1","key":"48445_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3109\/0284186X.2015.1114670","volume":"55","author":"JK Pedersen","year":"2016","unstructured":"Pedersen, J. K., Engholm, G., Skytthe, A. & Christensen, K. & Academy of Geriatric Cancer, R. Cancer and aging: Epidemiology and methodological challenges. Acta Oncol 55(Suppl 1), 7\u201312, https:\/\/doi.org\/10.3109\/0284186X.2015.1114670 (2016).","journal-title":"Acta Oncol"},{"key":"48445_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/0-387-23962-6_1","volume":"124","author":"L Balducci","year":"2005","unstructured":"Balducci, L. & Aapro, M. Epidemiology of cancer and aging. Cancer treatment and research 124, 1\u201315 (2005).","journal-title":"Cancer treatment and research"},{"key":"48445_CR23","first-page":"1","volume":"P25\u20131141","author":"SL Colby","year":"2014","unstructured":"Colby, S. L. & Ortman, J. M. The Baby Boom Cohort in the United States: 2012 to 2060. Current Population Reports P25\u20131141, 1\u201316 (2014).","journal-title":"Current Population Reports"},{"key":"48445_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0889-8588(05)70275-6","volume":"14","author":"R Yancik","year":"2000","unstructured":"Yancik, R. & Ries, L. A. Aging and cancer in America. Demographic and epidemiologic perspectives. Hematology\/oncology clinics of North America 14, 17\u201323 (2000).","journal-title":"Hematology\/oncology clinics of North America"},{"key":"48445_CR25","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/00130404-200511000-00002","volume":"11","author":"R Yancik","year":"2005","unstructured":"Yancik, R. Population aging and cancer: a cross-national concern. Cancer journal (Sudbury, Mass 11, 437\u2013441 (2005).","journal-title":"Cancer journal (Sudbury, Mass"},{"key":"48445_CR26","first-page":"6","volume":"48","author":"SH Landis","year":"1998","unstructured":"Landis, S. H., Murray, T., Bolden, S. & Wingo, P. A. Cancer statistics, 1998. CA: a cancer journal for clinicians 48, 6\u201329 (1998).","journal-title":"CA: a cancer journal for clinicians"},{"issue":"8\u201331","key":"48445_CR27","first-page":"31","volume":"49","author":"SH Landis","year":"1999","unstructured":"Landis, S. H., Murray, T., Bolden, S. & Wingo, P. A. Cancer statistics, 1999. CA: a cancer journal for clinicians 49(8\u201331), 31 (1999).","journal-title":"CA: a cancer journal for clinicians"},{"key":"48445_CR28","first-page":"7","volume":"50","author":"RT Greenlee","year":"2000","unstructured":"Greenlee, R. T., Murray, T., Bolden, S. & Wingo, P. A. Cancer statistics, 2000. CA: a cancer journal for clinicians 50, 7\u201333 (2000).","journal-title":"CA: a cancer journal for clinicians"},{"key":"48445_CR29","first-page":"15","volume":"51","author":"RT Greenlee","year":"2001","unstructured":"Greenlee, R. T., Hill-Harmon, M. B., Murray, T. & Thun, M. Cancer statistics, 2001. CA: a cancer journal for clinicians 51, 15\u201336 (2001).","journal-title":"CA: a cancer journal for clinicians"},{"key":"48445_CR30","first-page":"23","volume":"52","author":"A Jemal","year":"2002","unstructured":"Jemal, A., Thomas, A., Murray, T. & Thun, M. Cancer statistics, 2002. CA: a cancer journal for clinicians 52, 23\u201347 (2002).","journal-title":"CA: a cancer journal for clinicians"},{"key":"48445_CR31","first-page":"5","volume":"53","author":"A Jemal","year":"2003","unstructured":"Jemal, A. et al. Cancer statistics, 2003. CA: a cancer journal for clinicians 53, 5\u201326 (2003).","journal-title":"CA: a cancer journal for clinicians"},{"key":"48445_CR32","first-page":"8","volume":"54","author":"A Jemal","year":"2004","unstructured":"Jemal, A. et al. Cancer statistics, 2004. CA: a cancer journal for clinicians 54, 8\u201329 (2004).","journal-title":"CA: a cancer journal for clinicians"},{"key":"48445_CR33","first-page":"10","volume":"55","author":"A Jemal","year":"2005","unstructured":"Jemal, A. et al. Cancer statistics, 2005. CA: a cancer journal for clinicians 55, 10\u201330 (2005).","journal-title":"CA: a cancer journal for clinicians"},{"key":"48445_CR34","first-page":"106","volume":"56","author":"A Jemal","year":"2006","unstructured":"Jemal, A. et al. Cancer statistics, 2006. CA: a cancer journal for clinicians 56, 106\u2013130 (2006).","journal-title":"CA: a cancer journal for clinicians"},{"key":"48445_CR35","first-page":"43","volume":"57","author":"A Jemal","year":"2007","unstructured":"Jemal, A. et al. Cancer statistics, 2007. CA: a cancer journal for clinicians 57, 43\u201366 (2007).","journal-title":"CA: a cancer journal for clinicians"},{"key":"48445_CR36","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3322\/CA.2007.0010","volume":"58","author":"A Jemal","year":"2008","unstructured":"Jemal, A. et al. Cancer statistics, 2008. CA: a cancer journal for clinicians 58, 71\u201396, https:\/\/doi.org\/10.3322\/CA.2007.0010 (2008).","journal-title":"CA: a cancer journal for clinicians"},{"key":"48445_CR37","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3322\/caac.20006","volume":"59","author":"A Jemal","year":"2009","unstructured":"Jemal, A. et al. Cancer statistics, 2009. CA: a cancer journal for clinicians 59, 225\u2013249, https:\/\/doi.org\/10.3322\/caac.20006 (2009).","journal-title":"CA: a cancer journal for clinicians"},{"key":"48445_CR38","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal, A., Siegel, R., Xu, J. & Ward, E. Cancer statistics, 2010. CA: a cancer journal for clinicians 60, 277\u2013300, https:\/\/doi.org\/10.3322\/caac.20073 (2010).","journal-title":"CA: a cancer journal for clinicians"},{"key":"48445_CR39","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3322\/caac.20121","volume":"61","author":"R Siegel","year":"2011","unstructured":"Siegel, R., Ward, E., Brawley, O. & Jemal, A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA: a cancer journal for clinicians 61, 212\u2013236, https:\/\/doi.org\/10.3322\/caac.20121 (2011).","journal-title":"CA: a cancer journal for clinicians"},{"key":"48445_CR40","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2012. CA: a cancer journal for clinicians 62, 10\u201329, https:\/\/doi.org\/10.3322\/caac.20138 (2012).","journal-title":"CA: a cancer journal for clinicians"},{"key":"48445_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2013. CA: a cancer journal for clinicians 63, 11\u201330, https:\/\/doi.org\/10.3322\/caac.21166 (2013).","journal-title":"CA: a cancer journal for clinicians"},{"key":"48445_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel, R., Ma, J., Zou, Z. & Jemal, A. Cancer statistics, 2014. CA: a cancer journal for clinicians 64, 9\u201329, https:\/\/doi.org\/10.3322\/caac.21208 (2014).","journal-title":"CA: a cancer journal for clinicians"},{"key":"48445_CR43","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"RL Siegel","year":"2015","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2015. CA: a cancer journal for clinicians 65, 5\u201329, https:\/\/doi.org\/10.3322\/caac.21254 (2015).","journal-title":"CA: a cancer journal for clinicians"},{"key":"48445_CR44","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2016. CA: a cancer journal for clinicians 66, 7\u201330, https:\/\/doi.org\/10.3322\/caac.21332 (2016).","journal-title":"CA: a cancer journal for clinicians"},{"key":"48445_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer Statistics, 2017. CA: a cancer journal for clinicians 67, 7\u201330, https:\/\/doi.org\/10.3322\/caac.21387 (2017).","journal-title":"CA: a cancer journal for clinicians"},{"key":"48445_CR46","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Research Data (1973\u20132015), National Cancer Institute, DCCPS, Surveillance Research Program, released April 2018, based on the November 2017 submission."},{"key":"48445_CR47","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim, H. J., Fay, M. P., Feuer, E. J. & Midthune, D. N. Permutation tests for joinpoint regression with applications to cancer rates. Statistics in medicine 19, 335\u2013351 (2000).","journal-title":"Statistics in medicine"},{"key":"48445_CR48","unstructured":"Surveillance, E. & End Results (SEER) Program. (North American Association of Central Cancer Registries, Bethesda, MD, 2017)."},{"key":"48445_CR49","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","volume":"100","author":"JW Vardiman","year":"2002","unstructured":"Vardiman, J. W., Harris, N. L. & Brunning, R. D. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 100, 2292\u20132302, https:\/\/doi.org\/10.1182\/blood-2002-04-1199 (2002).","journal-title":"Blood"},{"key":"48445_CR50","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber, D. A. et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127, 2391\u20132405, https:\/\/doi.org\/10.1182\/blood-2016-03-643544 (2016).","journal-title":"Blood"},{"key":"48445_CR51","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1182\/blood-2010-08-301713","volume":"117","author":"S Kayser","year":"2011","unstructured":"Kayser, S. et al. The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML. Blood 117, 2137\u20132145, https:\/\/doi.org\/10.1182\/blood-2010-08-301713 (2011).","journal-title":"Blood"},{"key":"48445_CR52","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrc.2017.60","volume":"17","author":"ME McNerney","year":"2017","unstructured":"McNerney, M. E., Godley, L. A. & Le Beau, M. M. Therapy-related myeloid neoplasms: when genetics and environment collide. Nat Rev Cancer 17, 513\u2013527, https:\/\/doi.org\/10.1038\/nrc.2017.60 (2017).","journal-title":"Nat Rev Cancer"},{"key":"48445_CR53","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1182\/blood-2012-08-448068","volume":"121","author":"LM Morton","year":"2013","unstructured":"Morton, L. M. et al. Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975\u20132008. Blood 121, 2996\u20133004, https:\/\/doi.org\/10.1182\/blood-2012-08-448068 (2013).","journal-title":"Blood"},{"key":"48445_CR54","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1038\/leu.2014.132","volume":"28","author":"LM Morton","year":"2014","unstructured":"Morton, L. M. et al. Risk of myeloid neoplasms after solid organ transplantation. Leukemia 28, 2317\u20132323, https:\/\/doi.org\/10.1038\/leu.2014.132 (2014).","journal-title":"Leukemia"},{"key":"48445_CR55","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s10549-013-2773-x","volume":"142","author":"HG Kaplan","year":"2013","unstructured":"Kaplan, H. G., Malmgren, J. A., Li, C. I. & Calip, G. S. Age related risk of myelodysplastic syndrome and acute myeloid leukemia among breast cancer survivors. Breast cancer research and treatment 142, 629\u2013636, https:\/\/doi.org\/10.1007\/s10549-013-2773-x (2013).","journal-title":"Breast cancer research and treatment"},{"key":"48445_CR56","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1158\/1055-9965.EPI-16-0121","volume":"25","author":"LN Kohler","year":"2016","unstructured":"Kohler, L. N. et al. Adherence to Diet and Physical Activity Cancer Prevention Guidelines and Cancer Outcomes: A Systematic Review. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 25, 1018\u20131028, https:\/\/doi.org\/10.1158\/1055-9965.EPI-16-0121 (2016).","journal-title":"Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"key":"48445_CR57","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1002\/cphy.c120005","volume":"2","author":"JC Brown","year":"2012","unstructured":"Brown, J. C., Winters-Stone, K., Lee, A. & Schmitz, K. H. Cancer, physical activity, and exercise. Comprehensive Physiology 2, 2775\u20132809, https:\/\/doi.org\/10.1002\/cphy.c120005 (2012).","journal-title":"Comprehensive Physiology"},{"key":"48445_CR58","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1093\/jnci\/djr483","volume":"103","author":"VJ Cogliano","year":"2011","unstructured":"Cogliano, V. J. et al. Preventable exposures associated with human cancers. J Natl Cancer Inst 103, 1827\u20131839, https:\/\/doi.org\/10.1093\/jnci\/djr483 (2011).","journal-title":"J Natl Cancer Inst"},{"key":"48445_CR59","doi-asserted-by":"publisher","first-page":"E125","DOI":"10.1002\/ajh.23744","volume":"89","author":"S Fircanis","year":"2014","unstructured":"Fircanis, S., Merriam, P., Khan, N. & Castillo, J. J. The relation between cigarette smoking and risk of acute myeloid leukemia: an updated meta-analysis of epidemiological studies. Am J Hematol 89, E125\u2013132, https:\/\/doi.org\/10.1002\/ajh.23744 (2014).","journal-title":"Am J Hematol"},{"key":"48445_CR60","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.canep.2013.03.012","volume":"37","author":"JR Musselman","year":"2013","unstructured":"Musselman, J. R. et al. Risk of adult acute and chronic myeloid leukemia with cigarette smoking and cessation. Cancer epidemiology 37, 410\u2013416, https:\/\/doi.org\/10.1016\/j.canep.2013.03.012 (2013).","journal-title":"Cancer epidemiology"},{"key":"48445_CR61","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1158\/1055-9965.EPI-13-0093","volume":"22","author":"GC Kabat","year":"2013","unstructured":"Kabat, G. C. et al. Lifestyle and dietary factors in relation to risk of chronic myeloid leukemia in the NIH-AARP Diet and Health Study. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 22, 848\u2013854, https:\/\/doi.org\/10.1158\/1055-9965.EPI-13-0093 (2013).","journal-title":"Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"key":"48445_CR62","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJMra061808","volume":"355","author":"CT Jordan","year":"2006","unstructured":"Jordan, C. T., Guzman, M. L. & Noble, M. Cancer stem cells. N Engl J Med 355, 1253\u20131261, https:\/\/doi.org\/10.1056\/NEJMra061808 (2006).","journal-title":"N Engl J Med"},{"key":"48445_CR63","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1182\/blood-2017-06-746412","volume":"131","author":"G de Haan","year":"2018","unstructured":"de Haan, G. & Lazare, S. S. Aging of hematopoietic stem cells. Blood 131, 479\u2013487, https:\/\/doi.org\/10.1182\/blood-2017-06-746412 (2018).","journal-title":"Blood"},{"key":"48445_CR64","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1615\/CritRevOncog.2013010187","volume":"18","author":"M Roth","year":"2013","unstructured":"Roth, M., Wang, Z. & Chen, W. Y. Sirtuins in hematological aging and malignancy. Critical reviews in oncogenesis 18, 531\u2013547 (2013).","journal-title":"Critical reviews in oncogenesis"},{"key":"48445_CR65","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nrc.2016.8","volume":"16","author":"G Fabbri","year":"2016","unstructured":"Fabbri, G. & Dalla-Favera, R. The molecular pathogenesis of chronic lymphocytic leukaemia. Nat Rev Cancer 16, 145\u2013162, https:\/\/doi.org\/10.1038\/nrc.2016.8 (2016).","journal-title":"Nat Rev Cancer"},{"key":"48445_CR66","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ccr.2011.06.029","volume":"20","author":"Y Kikushige","year":"2011","unstructured":"Kikushige, Y. et al. Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia. Cancer Cell 20, 246\u2013259, https:\/\/doi.org\/10.1016\/j.ccr.2011.06.029 (2011).","journal-title":"Cancer Cell"},{"key":"48445_CR67","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1056\/NEJMoa1609324","volume":"376","author":"A Hochhaus","year":"2017","unstructured":"Hochhaus, A. et al. Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia. N Engl J Med 376, 917\u2013927, https:\/\/doi.org\/10.1056\/NEJMoa1609324 (2017).","journal-title":"N Engl J Med"},{"key":"48445_CR68","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1002\/cncr.26679","volume":"118","author":"X Huang","year":"2012","unstructured":"Huang, X., Cortes, J. & Kantarjian, H. Estimations of the increasing prevalence and plateau prevalence of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy. Cancer 118, 3123\u20133127, https:\/\/doi.org\/10.1002\/cncr.26679 (2012).","journal-title":"Cancer"},{"key":"48445_CR69","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.1182\/blood-2002-09-2780","volume":"101","author":"R Bhatia","year":"2003","unstructured":"Bhatia, R. et al. Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment. Blood 101, 4701\u20134707 (2003).","journal-title":"Blood"},{"key":"48445_CR70","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1182\/blood.V99.1.319","volume":"99","author":"SM Graham","year":"2002","unstructured":"Graham, S. M. et al. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood 99, 319\u2013325 (2002).","journal-title":"Blood"},{"key":"48445_CR71","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.1182\/blood.V99.10.3792","volume":"99","author":"MS Holtz","year":"2002","unstructured":"Holtz, M. S. et al. Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferation. Blood 99, 3792\u20133800 (2002).","journal-title":"Blood"},{"key":"48445_CR72","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1182\/blood-2011-02-335497","volume":"118","author":"JC Chomel","year":"2011","unstructured":"Chomel, J. C. et al. Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual disease. Blood 118, 3657\u20133660, https:\/\/doi.org\/10.1182\/blood-2011-02-335497 (2011).","journal-title":"Blood"},{"key":"48445_CR73","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/leu.2015.261","volume":"30","author":"M Pfirrmann","year":"2016","unstructured":"Pfirrmann, M. et al. Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia. Leukemia 30, 48\u201356, https:\/\/doi.org\/10.1038\/leu.2015.261 (2016).","journal-title":"Leukemia"},{"issue":"Suppl 2","key":"48445_CR74","doi-asserted-by":"publisher","first-page":"S159","DOI":"10.1007\/s00277-015-2324-0","volume":"94","author":"S Saussele","year":"2015","unstructured":"Saussele, S. & Silver, R. T. Management of chronic myeloid leukemia in blast crisis. Annals of hematology 94(Suppl 2), S159\u2013165, https:\/\/doi.org\/10.1007\/s00277-015-2324-0 (2015).","journal-title":"Annals of hematology"},{"key":"48445_CR75","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3109\/10428194.2013.845883","volume":"55","author":"EJ Jabbour","year":"2014","unstructured":"Jabbour, E. J., Hughes, T. P., Cortes, J. E., Kantarjian, H. M. & Hochhaus, A. Potential mechanisms of disease progression and management of advanced-phase chronic myeloid leukemia. Leukemia & lymphoma 55, 1451\u20131462, https:\/\/doi.org\/10.3109\/10428194.2013.845883 (2014).","journal-title":"Leukemia & lymphoma"},{"key":"48445_CR76","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1182\/blood-2013-05-498287","volume":"122","author":"M Hallek","year":"2013","unstructured":"Hallek, M. Signaling the end of chronic lymphocytic leukemia: new frontline treatment strategies. Blood 122, 3723\u20133734, https:\/\/doi.org\/10.1182\/blood-2013-05-498287 (2013).","journal-title":"Blood"},{"key":"48445_CR77","first-page":"288","volume":"23","author":"JB Yu","year":"2009","unstructured":"Yu, J. B., Gross, C. P., Wilson, L. D. & Smith, B. D. NCI SEER public-use data: applications and limitations in oncology research. Oncology 23, 288\u2013295 (2009).","journal-title":"Oncology"},{"key":"48445_CR78","unstructured":"Fritz, A. et al. (World Health Organization, Geneva, 2000)."},{"key":"48445_CR79","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/cncr.20910","volume":"103","author":"E Steliarova-Foucher","year":"2005","unstructured":"Steliarova-Foucher, E., Stiller, C., Lacour, B. & Kaatsch, P. International Classification of Childhood Cancer, Third Edition. Cancer 103, 1457\u20131467 (2005).","journal-title":"Cancer"},{"key":"48445_CR80","first-page":"861","volume":"9","author":"MJ Thun","year":"2000","unstructured":"Thun, M. J., Calle, E. E., Rodriguez, C. & Wingo, P. A. Epidemiological research at the American Cancer Society. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 9, 861\u2013868 (2000).","journal-title":"Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"key":"48445_CR81","unstructured":"Swerdlow, S. H. et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. (World Health Organization, 2008)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48445-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48445-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48445-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T12:43:36Z","timestamp":1671281016000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48445-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,19]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["48445"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-48445-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,19]]},"assertion":[{"value":"17 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12070"}}